Novacyt Statistics
Total Valuation
Novacyt has a market cap or net worth of 38.04 million. The enterprise value is 11.52 million.
| Market Cap | 38.04M |
| Enterprise Value | 11.52M |
Important Dates
The next estimated earnings date is Wednesday, April 30, 2025.
| Earnings Date | Apr 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.62 |
| PB Ratio | 0.43 |
| P/TBV Ratio | 0.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.24 |
| EV / Sales | 0.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.31 |
Financial Position
The company has a current ratio of 4.04, with a Debt / Equity ratio of 0.19.
| Current Ratio | 4.04 |
| Quick Ratio | 3.70 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.45 |
| Interest Coverage | -18.49 |
Financial Efficiency
Return on equity (ROE) is -42.04% and return on invested capital (ROIC) is -33.88%.
| Return on Equity (ROE) | -42.04% |
| Return on Assets (ROA) | -27.98% |
| Return on Invested Capital (ROIC) | -33.88% |
| Return on Capital Employed (ROCE) | -60.42% |
| Revenue Per Employee | 97,744 |
| Profits Per Employee | -198,220 |
| Employee Count | 237 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 10.81 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.60% in the last 52 weeks. The beta is 0.44, so Novacyt's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | +7.60% |
| 50-Day Moving Average | 0.77 |
| 200-Day Moving Average | 6.04 |
| Relative Strength Index (RSI) | 42.82 |
| Average Volume (20 Days) | 844 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novacyt had revenue of 23.46 million and -47.57 million in losses. Loss per share was -0.67.
| Revenue | 23.46M |
| Gross Profit | -13.85M |
| Operating Income | -65.51M |
| Pretax Income | -48.24M |
| Net Income | -47.57M |
| EBITDA | -48.34M |
| EBIT | -65.51M |
| Loss Per Share | -0.67 |
Balance Sheet
The company has 41.64 million in cash and 16.61 million in debt, giving a net cash position of 25.03 million.
| Cash & Cash Equivalents | 41.64M |
| Total Debt | 16.61M |
| Net Cash | 25.03M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 88.99M |
| Book Value Per Share | 1.26 |
| Working Capital | 52.30M |
Cash Flow
In the last 12 months, operating cash flow was -35.88 million and capital expenditures -1.41 million, giving a free cash flow of -37.29 million.
| Operating Cash Flow | -35.88M |
| Capital Expenditures | -1.41M |
| Free Cash Flow | -37.29M |
| FCF Per Share | n/a |
Margins
Gross margin is -59.05%, with operating and profit margins of -279.25% and -202.80%.
| Gross Margin | -59.05% |
| Operating Margin | -279.25% |
| Pretax Margin | -205.65% |
| Profit Margin | -202.80% |
| EBITDA Margin | -206.05% |
| EBIT Margin | -279.25% |
| FCF Margin | n/a |
Dividends & Yields
Novacyt does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -125.05% |
| FCF Yield | -98.01% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Novacyt has an Altman Z-Score of -0.03. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.03 |
| Piotroski F-Score | n/a |